Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Pegylated carboxyhaemoglobin

EU orphan designation number: EU/3/09/698   
Active ingredient: Pegylated carboxyhaemoglobin
Indication: Treatment of sickle cell disease
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
2/12/2009 Orphan designation EMEA/OD/075/09 (2009)9605 of 26/11/2009
22/05/2017 Change of name and/or address of sponsor